The Valley Desk

NCT04811560 · Interventional trial

A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)

Overall registry status Recruiting

Phase 1 · Phase 2

Conditions Acute Leukemia, Essential Thrombocythemia, Primary Myelofibrosis

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov